The Latest Headlines at American Banking and Market News
Cantor Fitzgerald Reiterates “Overweight” Rating for Taysha Gene Therapies (NASDAQ:TSHA)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued to clients and investors on Thursday,... More of this article »
Barrington Research Reiterates Outperform Rating for SuRo Capital (NASDAQ:SSSS)
SuRo Capital (NASDAQ:SSSS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a report issued on Thursday, Benzinga reports. They currently have a $6.00 target... More of this article »
HC Wainwright Reiterates “Buy” Rating for UroGen Pharma (NASDAQ:URGN)
UroGen Pharma (NASDAQ:URGN – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued on Thursday, MarketBeat Ratings reports. They currently have... More of this article »
Deutsche Bank Aktiengesellschaft Lowers Bio-Techne (NASDAQ:TECH) Price Target to $82.00
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price target dropped by Deutsche Bank Aktiengesellschaft from $85.00 to $82.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Ulta Beauty (NASDAQ:ULTA) PT Lowered to $520.00
Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price objective lowered by stock analysts at TD Cowen from $580.00 to $520.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently... More of this article »
Sprout Social (NASDAQ:SPT) Coverage Initiated at Oppenheimer
Stock analysts at Oppenheimer initiated coverage on shares of Sprout Social (NASDAQ:SPT – Get Free Report) in a research report issued on Thursday, Marketbeat Ratings reports. The firm set an “outperform” rating and... More of this article »
Tesla (NASDAQ:TSLA) Stock Rating Lowered by Deutsche Bank Aktiengesellschaft
Tesla (NASDAQ:TSLA – Get Free Report) was downgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a report issued on Thursday, MarketBeat Ratings... More of this article »
Wedbush Reiterates “Neutral” Rating for Tripadvisor (NASDAQ:TRIP)
Tripadvisor (NASDAQ:TRIP – Get Free Report)‘s stock had its “neutral” rating reiterated by Wedbush in a report released on Thursday, Benzinga reports. They presently have a $30.00 price objective on the travel... More of this article »
10x Genomics (NASDAQ:TXG) PT Lowered to $55.00
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target lowered by research analysts at Deutsche Bank Aktiengesellschaft from $60.00 to $55.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage... More of this article »
Q1 2026 EPS Estimates for Applied Industrial Technologies, Inc. (NYSE:AIT) Boosted by Analyst
Applied Industrial Technologies, Inc. (NYSE:AIT – Free Report) – Investment analysts at Zacks Research boosted their Q1 2026 EPS estimates for shares of Applied Industrial Technologies in a research note issued to investors... More of this article »
B. Riley Analysts Boost Earnings Estimates for Alcoa Co. (NYSE:AA)
Alcoa Co. (NYSE:AA – Free Report) – Research analysts at B. Riley raised their FY2025 earnings estimates for shares of Alcoa in a research report issued on Thursday, April 18th. B. Riley analyst L. Pipes now anticipates... More of this article »
Equities Analysts Offer Predictions for U.S. Bancorp’s Q2 2024 Earnings (NYSE:USB)
U.S. Bancorp (NYSE:USB – Free Report) – Equities researchers at DA Davidson issued their Q2 2024 earnings estimates for shares of U.S. Bancorp in a report issued on Thursday, April 18th. DA Davidson analyst P. Winter... More of this article »
Travelers Companies (NYSE:TRV) PT Lowered to $250.00
Travelers Companies (NYSE:TRV – Get Free Report) had its price objective cut by Evercore ISI from $253.00 to $250.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform”... More of this article »